ClinicalTrials.Veeva

Menu

Acceptance and Commitment Therapy for Chemsex (ACT-for-chemse)

The University of Alabama at Birmingham logo

The University of Alabama at Birmingham

Status

Not yet enrolling

Conditions

Chemsex

Treatments

Behavioral: ACT-for-chemsex
Other: Treatment as Usual (TAU)

Study type

Interventional

Funder types

Other

Identifiers

NCT06980974
IRB-300014764

Details and patient eligibility

About

Quasi-randomized control trial of acceptance and commitment therapy (ACT) for chemsex.

Full description

Intervention will entail a prescreening, intake session, 16 therapy sessions, and a six-month follow-up. Each session will be 45-55 minutes long. Participants in ACT-for-chemsex will be compared to participants in a treatment as usual condition.

Enrollment

100 estimated patients

Sex

Male

Ages

18 to 65 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Male
  • age 18-65
  • access to internet capable smart device
  • documentation of Alabama residence
  • access to a private area to attend tele ACT-for-chemsex sessions
  • self-reported chemsex within six-months of intake
  • English fluency.

Exclusion criteria

  • Psychotic disorder
  • bipolar disorder
  • eating disorder
  • major neurocognitive disorder diagnosis
  • self-harm or suicide attempt within 12 months of screener
  • suicide plan/intention at time of screening
  • ongoing treatment for a complex medical comorbidity (e.g., in patient cancer treatment)
  • current enrollment in an individual ACT-based psychotherapy intervention.

Trial design

Primary purpose

Treatment

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

100 participants in 2 patient groups

ACT-for-chemsex
Experimental group
Description:
16 weeks of ACT to reduce chemsex
Treatment:
Behavioral: ACT-for-chemsex
Treatment as usual
Active Comparator group
Description:
Treatment as usual
Treatment:
Other: Treatment as Usual (TAU)

Trial contacts and locations

1

Loading...

Central trial contact

Nicholas C Borgogna, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems